SYNTHESIS OF QUINAZOLINE DERIVATIVES AS GEFITINIB INTERMEDIATES

Cancer appears to be the second cause of death in the worldwide. Lung cancer is the second most common cancer variety with the highest death rate. Lung cancer is a disease caused by gene mutations in the Epidermal Growth Factor Receptor (EGFR) signalling pathway which causes excessive phosphor...

Full description

Saved in:
Bibliographic Details
Main Author: Auliya Hafizah, Raysa
Format: Final Project
Language:Indonesia
Subjects:
Online Access:https://digilib.itb.ac.id/gdl/view/81485
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:81485
spelling id-itb.:814852024-06-28T07:53:39ZSYNTHESIS OF QUINAZOLINE DERIVATIVES AS GEFITINIB INTERMEDIATES Auliya Hafizah, Raysa Kimia Indonesia Final Project Lung cancer, gefitinib, EGFR, demethylation, spectroscopy INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/81485 Cancer appears to be the second cause of death in the worldwide. Lung cancer is the second most common cancer variety with the highest death rate. Lung cancer is a disease caused by gene mutations in the Epidermal Growth Factor Receptor (EGFR) signalling pathway which causes excessive phosphorylation. One of the medications used for lung cancer is gefitinib. Gefitinib is a molecule that has an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor activity. In the previous study, the most important step in the synthesis of gefitinib was the demethylation process of the methoxy group at position 6 of 6,7-dimethoxy-3,4-dihydroquinazolin-4-one (1) using L-methionine and methanesulfonic acid to produce 6-hydroxy-7- methoxy-3,4-dihydroquinazoline-4-one (2), with a yield of 46%. Therefore, this study aims to optimize the demethylation process of 6-hydroxy-7- methoxy-3,4-dihydroquinazolin-4-one (2) by varying the temperature and equivalent, then the optimization results ware reacted with 4-(3-chloro-4-fluorophenylamino)-6,7-dimethoxy quinazoline (3) to produce 4-(3-chloro-4-fluorophenylamino)-6-hydroxy-7-methoxy quinazoline (4). Subsequently, the Williamson ether reaction was carried out to produce the intermediates N-(3- chloro-4-fluorophenyl)-6-(3-chloropropoxy)-7-methoxyquinazoline-4-amine (5) and 6-(4- bromobutoxy)-N-(3 -chloro-4-fluorophenyl)-7-methoxyquinazoline-4-amine (6). In this study, compound (2) was successfully synthesized with optimum reaction conditions at a temperature 120°C and equivalent ratio of precursor and L-methionine of 1:1,5 for 1 hour reaction with a HPLC yield of 74,4%, compound (4) with a yield of 49% , compound (5) with a yield of 31%, and compound (6) with a yield of 3.5%. The synthesized product was characterized by NMR spectroscopy (1H and 13C) and mass spectrometry text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
topic Kimia
spellingShingle Kimia
Auliya Hafizah, Raysa
SYNTHESIS OF QUINAZOLINE DERIVATIVES AS GEFITINIB INTERMEDIATES
description Cancer appears to be the second cause of death in the worldwide. Lung cancer is the second most common cancer variety with the highest death rate. Lung cancer is a disease caused by gene mutations in the Epidermal Growth Factor Receptor (EGFR) signalling pathway which causes excessive phosphorylation. One of the medications used for lung cancer is gefitinib. Gefitinib is a molecule that has an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor activity. In the previous study, the most important step in the synthesis of gefitinib was the demethylation process of the methoxy group at position 6 of 6,7-dimethoxy-3,4-dihydroquinazolin-4-one (1) using L-methionine and methanesulfonic acid to produce 6-hydroxy-7- methoxy-3,4-dihydroquinazoline-4-one (2), with a yield of 46%. Therefore, this study aims to optimize the demethylation process of 6-hydroxy-7- methoxy-3,4-dihydroquinazolin-4-one (2) by varying the temperature and equivalent, then the optimization results ware reacted with 4-(3-chloro-4-fluorophenylamino)-6,7-dimethoxy quinazoline (3) to produce 4-(3-chloro-4-fluorophenylamino)-6-hydroxy-7-methoxy quinazoline (4). Subsequently, the Williamson ether reaction was carried out to produce the intermediates N-(3- chloro-4-fluorophenyl)-6-(3-chloropropoxy)-7-methoxyquinazoline-4-amine (5) and 6-(4- bromobutoxy)-N-(3 -chloro-4-fluorophenyl)-7-methoxyquinazoline-4-amine (6). In this study, compound (2) was successfully synthesized with optimum reaction conditions at a temperature 120°C and equivalent ratio of precursor and L-methionine of 1:1,5 for 1 hour reaction with a HPLC yield of 74,4%, compound (4) with a yield of 49% , compound (5) with a yield of 31%, and compound (6) with a yield of 3.5%. The synthesized product was characterized by NMR spectroscopy (1H and 13C) and mass spectrometry
format Final Project
author Auliya Hafizah, Raysa
author_facet Auliya Hafizah, Raysa
author_sort Auliya Hafizah, Raysa
title SYNTHESIS OF QUINAZOLINE DERIVATIVES AS GEFITINIB INTERMEDIATES
title_short SYNTHESIS OF QUINAZOLINE DERIVATIVES AS GEFITINIB INTERMEDIATES
title_full SYNTHESIS OF QUINAZOLINE DERIVATIVES AS GEFITINIB INTERMEDIATES
title_fullStr SYNTHESIS OF QUINAZOLINE DERIVATIVES AS GEFITINIB INTERMEDIATES
title_full_unstemmed SYNTHESIS OF QUINAZOLINE DERIVATIVES AS GEFITINIB INTERMEDIATES
title_sort synthesis of quinazoline derivatives as gefitinib intermediates
url https://digilib.itb.ac.id/gdl/view/81485
_version_ 1822997337003261952